Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T06:10:56.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new publication has been added detailing study results on blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer, while several older entries from late 2022 have been removed.
    Difference
    4%
    Check dated 2024-08-28T03:24:31.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T00:05:10.000Z thumbnail image
  5. Check
    32 days ago
    No Change Detected
  6. Check
    47 days ago
    Change Detected
    Summary
    The study has expanded to include 15 locations, and the software has been updated from version v2.9.7 to v2.10.0.
    Difference
    0.3%
    Check dated 2024-07-23T14:42:40.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:08:50.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T13:09:44.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.